BU-NOT-SET

CONTACT US
The Recipharm Journey
  • Corporate
Eyes
Insight
Solubility enhancement
  • Drug substance
Man holding liquid container
Fact sheet
Unlocking the key changes to Annex 1
  • Manufacturing
Eyes
Insight
Trends impacting drug dosage forms
  • Drug product
Product line
Insight
Relocation of the production of pharmaceuticals: a strategic endeavour for the European Union
  • Industry trends
Eyes
Insight
Outsourcing solid dose manufacturing trends
  • Manufacturing
Eyes
Insight
Strategic outsourcing of analytical testing solutions to speed up time-to-market
  • Analytical chemistry
Eyes
Insight
Recipharm Cannabinoids
  • Drug product
Eyes
Insight
Explore Recipharm's Full Service Offering
  • Corporate
Recipharm_packaging
Brochure
Insight
  • Biologics
Unlocking the potential of RNA therapeutics through innovation and collaboration
White paper
  • Analytical chemistry
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach